The National Group of Expertise on Pancreatic Cancer Research (KNEP) consists of nine research groups from Oslo, Bergen and Stavanger. Through a joint 5-years project supported by the Norwegian Cancer Society, the groups have bundled their research activities to improve early diagnostics and treatment of pancreatic cancer.
The aim of our project is to stimulate collaboration across disciplines and institutions, and to join experts in the field of pancreatic cancer in order to strengthen research on this disease. The research groups will exchange data and biomaterials so that complex associations between various aspects of pancreatic cancer can be identified at the individual patient level. We seek to achieve much-needed, concrete progress in the management of pancreatic cancer patients. Through its collaborative network, KNEP will establish a competitive and sustainable research environment for pancreatic cancer in Norway.
The consortium comprises the following nine work packages
The research portfolio of KNEP comprises studies in the central clinical fields of
Surgery
Oncology
Medical Genetics
In addition to laboratory studies on:
Multi-omics characterization of tumor tissue
High-throughput drug screening
Histopathology
Metabolomics
Animal models for pancreatic cancer
The research groups are based in Oslo, Bergen, and Stavanger, and collaborate with patients from all over Norway. The University of Oslo is the host institution for this 5-years project.
May 2020 - April 2025
Stay informed about research and activities conducted by KNEP - the Norwegian Cancer Society’s National Group of Expertise on Pancreatic Cancer Research.
The annual national network meeting on pancreatic cancer research will be held on March 13, 2026, at the Grand Hotel in Oslo. The meeting is organized by the Norwegian Cancer Society's National Group of Expertise for Research on Pancreatic Cancer (KNEP; https://knep.no/). The program will include presentations by both international and Norwegian researchers and will conclude with an anniversary celebration to mark the 10th anniversary of the Pancreatic Cancer Network Norway (PKNN). It will be possible to submit requests to contribute with your own presentations.Please save the date of March 13.
KNEP researchers from Stavanger University Hospital presented new results last week at the ISMRC (International Symposium on Minimal Residual Cancer) research conference in Nice, France. The results showed a slight improvement in the detection of cancer DNA in blood by using the new methods.
As the 3rd in a series that started in 2022, a national meeting was held at Thon Hotel Opera, Oslo, on January 30, 2025. The meeting programme included 12 presentations from clinical, translational and basic research groups as well as a presentation by the Norwegian Cancer Society about its role in cancer research. A promising young pancreatic cancer researcher was honoured with a travel stipend granted by the Norwegian pancreatic cancer patient organisation PKNN.
We will get back to you ASAP via email.
